Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3145 results found
Expand All
Apply All
3145 results found

National and Local Companies Form New Mexico Clean Fuels Coalition to Support Diversification of State's Economy
Share
Agriculture & Environment, Sustainable Fuels, Climate Change  •  Press Release  •  March 5, 2021
Albuquerque, NM (March 5, 2021) – In response to New Mexico’s proposed Clean Fuel Standard legislation, 21 national and New Mexico-based companies and organizations formed the New Mexico Clean Fuel Coalition to support the state’s efforts to diversify New Mexico’s economy while decreasing greenhouse gas emissions. The Coalition was formed in conjunction with the Low Carbon Fuels Coalition, a national organization that plays a leading role in helping shape clean fuel policy at state and national levels. If enacted, the Clean Fuel Standard Act, SB 11, would establish a market-based approach to cut greenhouse gas emissions from transportation fuels, requiring fuel producers and importers to reduce the amount of carbon in fuels used in New Mexico —a 10% reduction by 2030 and a 28% reduction by 2040. Fuel producers and importers can meet the reduction goals by purchasing credits if they are not able to produce sufficiently low-carbon fuels. Credits may be generated from any business in any sector of New Mexico’s economy – including the agriculture, chemical, dairy, energy, forestry, manufacturing, mining, oil and gas, waste management and wastewater treatment industries. “This proposed legislation aligns with the Coalition’s mission to support market-based clean fuel policies in the United States,” said Graham Noyes, Executive Director of the Low Carbon Fuels Coalition. “We are excited about this new business coalition forming in New Mexico and look forward to working with the Governor and her leadership team on this legislation and on future clean fuel policies.” Adelante Consulting, Inc., is coordinating efforts of the New Mexico Fuels Coalition. Adelante is a New Mexico-based firm with expertise in market-based trading programs and a member of the Low Carbon Fuels Coalition. Adelante Consulting identified the adoption of a low carbon fuel standard in New Mexico as a key policy prerequisite to attract bio-based industry to the state in a feasibility study for…
Read More

What’s happening in the state legislatures
Share
Good Day BIO Newsletter  •  March 5, 2021
While we’re waiting for news from the Senate on the COVID-19 relief package, we caught up with Patrick Plues, BIO’s VP of State Government Affairs, to get an update on the state legislatures and some of the 600+ bills BIO’s tracking and engaging on covering health care, agriculture, and economic development. (1205 words, 6 minutes)
Read More

Why Biden’s pandemic agenda cannot ignore superbugs
Share
Good Day BIO Newsletter  •  March 4, 2021
Today, Dr. Michelle tells us why we must not ignore superbugs as we prepare for future pandemics. Also, we have news about LanzaTech’s new partnership to make perfume more sustainable, and an announcement about BIO Digital 2021. (671 words, 3 minutes, 21 seconds)
Read More

BIO Supports Emergency Relief for Black Farmers as Part of COVID Relief
Share
Agriculture & Environment, Climate Change  •  Letters, Testimony & Comments  •  March 3, 2021
The Biotechnology Innovation Organization (BIO) applauds the introduction of the Emergency Relief for Farmers of Color Act and welcomes the inclusion of provisions from this legislation in the American Rescue Plan.  BIO is committed to championing broad access to biotech breakthroughs and scientific equality and welcomes the opportunity to work with Congress and the Administration to meet the challenges of inequity head on.
Read More

A shot in the arm
Share
Good Day BIO Newsletter  •  March 3, 2021
Today we have details on yesterday's significant announcement from Merck and Johnson & Johnson, as well as a look at the sustainable genetically engineered salmon that might be coming to a supermarket near you this spring. (724 words, 3 minutes, 27 seconds)P.S. Don't miss what Dolly Parton had to say—and sing—about getting her COVID-19 vaccine.
Read More

This new test can detect COVID-19 variants—quickly
Share
Good Day BIO Newsletter  •  March 2, 2021
Today, news on a new diagnostic that can detect COVID-19 variants—and a vaccine that looks like it might prevent them. We have details, plus the woman whose research led to the first genetically modified plants. (674 words, 3 minutes, 22 seconds)
Read More

A third COVID-19 vaccine
Share
Good Day BIO Newsletter  •  March 1, 2021
It’s March, again—but things are looking up because the FDA authorized a third COVID-19 vaccine for emergency use. We have details, plus USDA’s proposed framework for regulatory oversight of animal biotech, and our Women’s History Month kickoff. (930 words, 4 minutes, 39 seconds)
Read More

BIO Comments on USDA Rulemaking on Animal Biotechnology
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  February 26, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Department of Agriculture’s (USDA’s) advance notice of proposed rulemaking and request for public comment on a proposed framework for oversight of certain animals modified or developed through genetic engineering. In particular, USDA proposes a new regulatory framework for amenable species intended for agricultural use, to be administered jointly by USDA’s Animal and Plant Health Inspection Service (APHIS) and the Food Safety Inspection Service (FSIS). The use of biotechnology to improve the genetics of animals used in agriculture has the potential to address a broad array of important societal issues—improvements in animal health and welfare; improved human health and nutrition; responding effectively to zoonotic disease; adaptation to climate change; and increasing the sustainability of animal agricultural production. The success of these innovations is critically dependent on regulatory systems that ensure animal health and welfare, food safety, and protection of the environment, but does so in a way that does not disincentivize development and commercialization of innovation. Without an efficient and effective system for oversight of animal biotechnology, the U.S. risks its leadership role in utilizing important, cutting-edge tools to address these critical societal challenges. The U.S. Food and Drug Administration (FDA) currently regulates the safety of animals containing “intentional genomic alterations” utilizing the new animal drug authority of the Federal Food, Drug, and Cosmetics Act (FFDCA), as described in draft “Guidance for Industry #187” (GFI 187).2 For reasons discussed in more detail below, BIO has long expressed concern over FDA’s approach to oversight of animal biotechnology, the implementation of which is having real and immediate impacts on our members and the U.S.’s ability to remain the leader in animal biotechnology. We appreciate…
Read More

BIO, as part of a coalition of other trade associations, wrote a letter to House leadership in support of H.R. 5, the Equality Act.
Share
Letters, Testimony & Comments  •  February 26, 2021
Equality of opportunity is a key pillar of our great democracy—one that allows all people to pursue their American Dream—and part of what makes our nation exceptional. Our industries, representing and employing tens of millions of Americans, understand this basic fact and have been at the forefront of efforts to combat discrimination based on sexual orientation and gender identity in the workplace.
Read More

Yesterday's Senate confirmation hearings – plus Rare Disease Day news
Share
Good Day BIO Newsletter  •  February 26, 2021
Today, everything you need to know about key health, trade, and energy Senate hearings yesterday, plus Rare Disease Day activities and an exclusive Q&A with Global Blood Therapeutics CEO Dr. Ted Love. (1037 words, 5 min.) We offer heartfelt condolences to the family of Sam Taylor, CEO of NCBIO, who passed away this past Sunday after a battle with pancreatic cancer. Sam drove North Carolina’s life sciences industry to become one of the largest in the nation—and represents the best biotech has to offer.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 193
  • 194
  • 195
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO